Ancestral dichlorodiphenyltrichloroethane (DDT) exposure promotes epigenetic transgenerational inheritance of obesity

BMC Medicine

Volumn 11, Issue 1, 2013, Pages

  Skinner, Michael K ^a   Manikkam, Mohan ^a   Tracey, Rebecca ^a   Guerrero Bosagna, Carlos ^a   Haque, Muksitul ^a   Nilsson, Eric E ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Disease etiology; Environmental epigenetics; Epimutations; Maternal transmission; Metabolic syndrome; Obesity associated disease

Indexed keywords

CHLORPHENOTANE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DISEASE TRANSMISSION; DNA ISOLATION; DNA METHYLATION; ENVIRONMENTAL EXPOSURE; EPIGENETIC TRANSGENERATIONAL INHERITANCE; EPIGENETICS; FEMALE; FETUS; GENE MUTATION; GENETIC ASSOCIATION; GERM LINE; INHERITANCE; KIDNEY; KIDNEY DISEASE; MALE; METABOLIC SYNDROME X; NONHUMAN; OBESITY; OUTBRED RAT STRAIN; OVARY; OVARY DISEASE; PROGENY; PROSTATE DISEASE; RAT; SPERM; TESTIS;

ANIMALS; CHROMOSOMES; DDT; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE REGULATORY NETWORKS; HUMANS; MALE; MATERNAL EXPOSURE; MUTATION; OBESITY; RATS; RATS, SPRAGUE-DAWLEY; SPERMATOZOA;

EID: 84887980478     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-11-228     Document Type: Article

References (78)

1. Skinner MK, Manikkam M, Guerrero-Bosagna C. Epigenetic transgenerational actions of environmental factors in disease etiology. Trends Endocrinol Metab 2010, 21:214-222. 10.1016/j.tem.2009.12.007, 2848884, 20074974.
2. Jirtle RL, Skinner MK. Environmental epigenomics and disease susceptibility. Nat Rev Genet 2007, 8:253-262. 10.1038/nrg2045, 17363974.
3. Skinner MK. Environmental epigenetic transgenerational inheritance and somatic epigenetic mitotic stability. Epigenetics 2011, 6:838-842. 10.4161/epi.6.7.16537, 21637037.
4. Anway MD, Cupp AS, Uzumcu M, Skinner MK. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 2005, 308:1466-1469. 10.1126/science.1108190, 15933200.
5. Anway MD, Leathers C, Skinner MK. Endocrine disruptor vinclozolin induced epigenetic transgenerational adult-onset disease. Endocrinology 2006, 147:5515-5523. 10.1210/en.2006-0640, 16973726.
6. Stouder C, Paoloni-Giacobino A. Transgenerational effects of the endocrine disruptor vinclozolin on the methylation pattern of imprinted genes in the mouse sperm. Reproduction 2010, 139:373-379. 10.1530/REP-09-0340, 19887539.
7. Manikkam M, Guerrero-Bosagna C, Tracey R, Haque MM, Skinner MK. Transgenerational Actions of Environmental Compounds on Reproductive Disease and Epigenetic Biomarkers of Ancestral Exposures. PLoS ONE 2012, 7:e31901. 10.1371/journal.pone.0031901, 3289630, 22389676.
8. Nilsson EE, Schindler R, Savenkova MI, Skinner MK. Inhibitory actions of anti-Mullerian hormone (AMH) on ovarian primordial follicle assembly. PLoS ONE 2011, 6:e20087. 10.1371/journal.pone.0020087, 3103528, 21637711.
9. Bruner-Tran KL, Osteen KG. Developmental exposure to TCDD reduces fertility and negatively affects pregnancy outcomes across multiple generations. Reprod Toxicol 2011, 31:344-350. 10.1016/j.reprotox.2010.10.003, 3044210, 20955784.
10. Waterland RA, Travisano M, Tahiliani KG, Rached MT, Mirza S. Methyl donor supplementation prevents transgenerational amplification of obesity. Int J Obes (Lond) 2008, 32:1373-1379.
11. Hauser MT, Aufsatz W, Jonak C, Luschnig C. Transgenerational epigenetic inheritance in plants. Biochim Biophys Acta 1809, 2011:459-468.
12. Ruden DM, Lu X. Hsp90 affecting chromatin remodeling might explain transgenerational epigenetic inheritance in Drosophila. Curr Genomics 2008, 9:500-508. 10.2174/138920208786241207, 2691676, 19506739.
13. Greer EL, Maures TJ, Ucar D, Hauswirth AG, Mancini E, Lim JP, Benayoun BA, Shi Y, Brunet A. Transgenerational epigenetic inheritance of longevity in Caenorhabditis elegans. Nature 2011, 479:365-371. 10.1038/nature10572, 3368121, 22012258.
14. Pembrey ME. Male-line transgenerational responses in humans. Hum Fertil (Camb) 2010, 13:268-271.
15. Guimaraes RM, Asmus CI, Meyer A. DDT reintroduction for malaria control: the cost-benefit debate for public health. Cad Saude Publica 2007, 23:2835-2844. 10.1590/S0102-311X2007001200004, 18157325.
16. Sadasivaiah S, Tozan Y, Breman JG. Dichlorodiphenyltrichloroethane (DDT) for indoor residual spraying in Africa: how can it be used for malaria control?. Am J Trop Med Hyg 2007, 77:249-263.
17. Davies K. Strategies for eliminating and reducing persistent bioaccumulative toxic substances: common approaches, emerging trends, and level of success. J Environ Health 2006, 69:9-15.
18. Enayati A, Hemingway J. Malaria management: past, present, and future. Annu Rev Entomol 2010, 55:569-591. 10.1146/annurev-ento-112408-085423, 19754246.
19. van den Berg H. Global status of DDT and its alternatives for use in vector control to prevent disease. Environ Health Perspect 2009, 117:1656-1663. 10.1289/ehp.0900785, 2801202, 20049114.
20. Aneck-Hahn NH, Schulenburg GW, Bornman MS, Farias P, de Jager C. Impaired semen quality associated with environmental DDT exposure in young men living in a malaria area in the Limpopo Province, South Africa. J Androl 2007, 28:423-434.
21. Hauser R, Singh NP, Chen Z, Pothier L, Altshul L. Lack of an association between environmental exposure to polychlorinated biphenyls and p, p'-DDE and DNA damage in human sperm measured using the neutral comet assay. Hum Reprod 2003, 18:2525-2533. 10.1093/humrep/deg508, 14645167.
22. ATSDR Agency for Toxic Substances and Diseases Registry (ATSDR)/US Public Health Service, Toxicological Profile for 4,4'-DDT, 4,4'-DDE, 4, 4'-DDD (Update) 1994, Atlanta, GA: ATSDR, ATSDR.
23. Longnecker MP, Klebanoff MA, Zhou H, Brock JW. Association between maternal serum concentration of the DDT metabolite DDE and preterm and small-for-gestational-age babies at birth. Lancet 2001, 358:110-114. 10.1016/S0140-6736(01)05329-6, 11463412.
24. Jaga K, Brosius D. Pesticide exposure: human cancers on the horizon. Rev Environ Health 1999, 14:39-50.
25. Hamlin HJ, Guillette LJ. Birth defects in wildlife: the role of environmental contaminants as inducers of reproductive and developmental dysfunction. Syst Biol Reprod Med 2010, 56:113-121. 10.3109/19396360903244598, 20377310.
26. Eskenazi B, Chevrier J, Rosas LG, Anderson HA, Bornman MS, Bouwman H, Chen A, Cohn BA, de Jager C, Henshel DS, Leipzig F, Leipzig JS, Lorenz EC, Snedeker SM, Stapleton D. The Pine River statement: human health consequences of DDT use. Environ Health Perspect 2009, 117:1359-1367. 2737010, 19750098.
27. Valvi D, Mendez MA, Martinez D, Grimalt JO, Torrent M, Sunyer J, Vrijheid M. Prenatal concentrations of polychlorinated biphenyls, DDE, and DDT and overweight in children: a prospective birth cohort study. Environ Health Perspect 2012, 120:451-457. 10.1289/ehp.1206266, 3295349, 22027556.
28. McAllister EJ, Dhurandhar NV, Keith SW, Aronne LJ, Barger J, Baskin M, Benca RM, Biggio J, Boggiano MM, Eisenmann JC, Elobeid M, Fontaine KR, Gluckman P, Hanlon EC, Katzmarzyk P, Pietrobelli A, Redden DT, Ruden DM, Wang C, Waterland RA, Wright SM, Allison DB. Ten putative contributors to the obesity epidemic. Crit Rev Food Sci Nutr 2009, 49:868-913. 10.1080/10408390903372599, 2932668, 19960394.
29. Caballero B. The global epidemic of obesity: an overview. Epidemiol Rev 2007, 29:1-5. 10.1093/epirev/mxm012, 17569676.
30. Trasande L, Attina TM, Blustein J. Association between urinary bisphenol A concentration and obesity prevalence in children and adolescents. JAMA 2012, 308:1113-1121. 10.1001/2012.jama.11461, 22990270.
31. Manikkam M, Tracey R, Guerrero-Bosagna C, Skinner M. Plastics derived endocrine disruptors (BPA, DEHP and DBP) Induce epigenetic transgenerational inheritance of adult-onset disease and sperm epimutations. PLoS ONE 2013, 8:e55387. 10.1371/journal.pone.0055387, 3554682, 23359474.
32. Tracey R, Manikkam M, Guerrero-Bosagna C, Skinner M. Hydrocarbon (Jet Fuel JP-8) induces epigenetic transgenerational inheritance of adult-onset disease and sperm epimutations. Reprod Toxicol 2013, 36:104-116.
33. Janesick A, Blumberg B. Obesogens, stem cells and the developmental programming of obesity. Int J Androl 2012, 35:437-448. 10.1111/j.1365-2605.2012.01247.x, 3358413, 22372658.
34. Sabin MA, Werther GA, Kiess W. Genetics of obesity and overgrowth syndromes. Best Pract Res Clin Endocrinol Metab 2011, 25:207-220. 10.1016/j.beem.2010.09.010, 21396586.
35. Phan-Hug F, Beckmann JS, Jacquemont S. Genetic testing in patients with obesity. Best Pract Res Clin Endocrinol Metab 2012, 26:133-143. 10.1016/j.beem.2011.11.010, 22498244.
36. Waterland RA. Is epigenetics an important link between early life events and adult disease?. Horm Res 2009, 71:13-16. 10.1159/000178030, 19153498.
37. Anderson PJ, Critchley JA, Chan JC, Cockram CS, Lee ZS, Thomas GN, Tomlinson B. Factor analysis of the metabolic syndrome: obesity vs insulin resistance as the central abnormality. Int J Obes Relat Metab Disord 2001, 25:1782-1788. 10.1038/sj.ijo.0801837, 11781758.
38. Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991, 34:416-422. 10.1007/BF00403180, 1884900.
39. Franks S. Polycystic ovary syndrome. N Engl J Med 1995, 333:853-861. 10.1056/NEJM199509283331307, 7651477.
40. Lauenborg J, Mathiesen E, Hansen T, Glumer C, Jorgensen T, Borch-Johnsen K, Hornnes P, Pedersen O, Damm P. The prevalence of the metabolic syndrome in a Danish population of women with previous gestational diabetes mellitus is three-fold higher than in the general population. J Clin Endocrinol Metab 2005, 90:4004-4010. 10.1210/jc.2004-1713, 15840755.
41. Chen SH, He F, Zhou HL, Wu HR, Xia C, Li YM. Relationship between nonalcoholic fatty liver disease and metabolic syndrome. J Dig Dis 2011, 12:125-130. 10.1111/j.1751-2980.2011.00487.x, 21401898.
42. Akahoshi T, Uematsu A, Akashiba T, Nagaoka K, Kiyofuji K, Kawahara S, Hattori T, Kaneita Y, Yoshizawa T, Takahashi N, Uchiyama M, Hashimoto S. Obstructive sleep apnoea is associated with risk factors comprising the metabolic syndrome. Respirology 2010, 15:1122-1126. 10.1111/j.1440-1843.2010.01818.x, 20723141.
43. Mathew AV, Okada S, Sharma K. Obesity related kidney disease. Curr Diabetes Rev 2011, 7:41-49. 10.2174/157339911794273928, 21067508.
44. Kasturi SS, Tannir J, Brannigan RE. The metabolic syndrome and male infertility. J Androl 2008, 29:251-259. 10.2164/jandrol.107.003731, 18222914.
45. Rahmanpour H, Jamal L, Mousavinasab SN, Esmailzadeh A, Azarkhish K. Association between polycystic ovarian syndrome, overweight, and metabolic syndrome in adolescents. J Pediatr Adolesc Gynecol 2012, 25:208-212. 10.1016/j.jpag.2012.02.004, 22578482.
46. Motta AB. The role of obesity in the development of polycystic ovary syndrome. Curr Pharm Des 2012, 18:2482-2491. 10.2174/13816128112092482, 22376149.
47. Beard J. DDT and human health. Sci Total Environ 2006, 355:78-89. 10.1016/j.scitotenv.2005.02.022, 15894351.
48. Nilsson EE, Anway MD, Stanfield J, Skinner MK. Transgenerational epigenetic effects of the endocrine disruptor vinclozolin on pregnancies and female adult onset disease. Reproduction 2008, 135:713-721. 10.1530/REP-07-0542, 18304984.
49. Xie F, Zhang R, Yang C, Xu Y, Wang N, Sun L, Liu J, Wei R, Ai J. Long-term neuropeptide Y administration in the periphery induces abnormal baroreflex sensitivity and obesity in rats. Cell Physiol Biochem 2012, 29:111-120. 10.1159/000337592, 22415080.
50. Phillips LK, Prins JB. The link between abdominal obesity and the metabolic syndrome. Curr Hypertens Rep 2008, 10:156-164. 10.1007/s11906-008-0029-7, 18474184.
51. National Task Force on the Prevention and Treatment of Obesity Overweight, obesity, and health risk. Arch Intern Med 2000, 160:898-904. National Task Force on the Prevention and Treatment of Obesity.
52. Anway MD, Skinner MK. Transgenerational effects of the endocrine disruptor vinclozolin on the prostate transcriptome and adult onset disease. Prostate 2008, 68:517-529. 10.1002/pros.20724, 18220299.
53. Taylor JA, Richter CA, Ruhlen RL, vom Saal FS. Estrogenic environmental chemicals and drugs: mechanisms for effects on the developing male urogenital system. J Steroid Biochem Mol Biol 2011, 127:83-95. 10.1016/j.jsbmb.2011.07.005, 3191287, 21827855.
54. Meredith S, Dudenhoeffer G, Jackson K. Classification of small type B/C follicles as primordial follicles in mature rats. J Reprod Fertil 2000, 119:43-48.
55. Tateno H, Kimura Y, Yanagimachi R. Sonication per se is not as deleterious to sperm chromosomes as previously inferred. Biol Reprod 2000, 63:341-346. 10.1095/biolreprod63.1.341, 10859277.
56. Ward WS, Kimura Y, Yanagimachi R. An intact sperm nuclear matrix may be necessary for the mouse paternal genome to participate in embryonic development. Biol Reprod 1999, 60:702-706. 10.1095/biolreprod60.3.702, 10026119.
57. Guerrero-Bosagna C, Settles M, Lucker B, Skinner M. Epigenetic transgenerational actions of vinclozolin on promoter regions of the sperm epigenome. PLoS ONE 2010, 5:e13100. 10.1371/journal.pone.0013100, 2948035, 20927350.
58. Guillette LJ, Gross TS, Masson GR, Matter JM, Percival HF, Woodward AR. Developmental abnormalities of the gonad and abnormal sex hormone concentrations in juvenile alligators from contaminated and control lakes in Florida. Environ Health Perspect 1994, 102:680-688. 10.1289/ehp.94102680, 1567320, 7895709.
59. Crews D, Gillette R, Scarpino SV, Manikkam M, Savenkova MI, Skinner MK. Epigenetic transgenerational inheritance of altered stress responses. Proc Natl Acad Sci U S A 2012, 109:9143-9148. 10.1073/pnas.1118514109, 3384163, 22615374.
60. Nilsson E, Larsen G, Manikkam M, Guerrero-Bosagna C, Savenkova M, Skinner M. Environmentally induced epigenetic transgenerational inheritance of ovarian disease. PLoS ONE 2012, 7:e36129. 10.1371/journal.pone.0036129, 3343040, 22570695.
61. McGrowder DA, Jackson LA, Crawford TV. Prostate cancer and metabolic syndrome: is there a link?. Asian Pac J Cancer Prev 2012, 13:1-13. 10.7314/APJCP.2012.13.1.001, 22502649.
62. Nelson RA, Bremer AA. Insulin resistance and metabolic syndrome in the pediatric population. Metab Syndr Relat Disord 2010, 8:1-14. 10.1089/met.2009.0068, 19943799.
63. Rose DP, Haffner SM, Baillargeon J. Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women. Endocr Rev 2007, 28:763-777. 10.1210/er.2006-0019, 17981890.
64. Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 2004, 15:2792-2800. 10.1097/01.ASN.0000141966.69934.21, 15504932.
65. Cao J, Rebuli ME, Rogers J, Todd KL, Leyrer SM, Ferguson SA, Patisaul HB. Prenatal bisphenol a exposure alters sex-specific estrogen receptor expression in the neonatal rat hypothalamus and amygdala. Toxicol Sci 2013, 133:157-173. 10.1093/toxsci/kft035, 23457122.
66. McMillen IC, Rattanatray L, Duffield JA, Morrison JL, MacLaughlin SM, Gentili S, Muhlhausler BS. The early origins of later obesity: pathways and mechanisms. Adv Exp Med Biol 2009, 646:71-81. 10.1007/978-1-4020-9173-5_8, 19536665.
67. Massiera F, Barbry P, Guesnet P, Joly A, Luquet S, Moreilhon-Brest C, Mohsen-Kanson T, Amri EZ, Ailhaud G. A Western-like fat diet is sufficient to induce a gradual enhancement in fat mass over generations. J Lipid Res 2010, 51:2352-2361. 10.1194/jlr.M006866, 2903802, 20410018.
68. Dunn GA, Bale TL. Maternal high-fat diet effects on third-generation female body size via the paternal lineage. Endocrinology 2011, 152:2228-2236. 10.1210/en.2010-1461, 3100614, 21447631.
69. Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R. Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord 2002, 26:883-896.
70. Martinez-Bermejo E, Luque-Ramirez M, Escobar-Morreale HF. Obesity and the polycystic ovary syndrome. Minerva Endocrinol 2007, 32:129-140.
71. Doyle TJ, Bowman JL, Windell VL, McLean DJ, Kim KH. Transgenerational effects of di-(2-ethylhexyl) phthalate on testicular germ cell associations and spermatogonial stem cells in mice. Biol Reprod 2013, 88:112. 10.1095/biolreprod.112.106104, 23536373.
72. Maric-Bilkan C. Obesity and diabetic kidney disease. Med Clin North Am 2013, 97:59-74. 10.1016/j.mcna.2012.10.010, 23290730.
73. Mlambo SS, van Vuren JH, Barnhoorn IE, Bornman MS. Histopathological changes in the reproductive system (ovaries and testes) of Oreochromis mossambicus following exposure to DDT. Environ Toxicol Pharmacol 2009, 28:133-139. 10.1016/j.etap.2009.03.011, 21783993.
74. Cohn BA, Cirillo PM, Christianson RE. Prenatal DDT exposure and testicular cancer: a nested case-control study. Arch Environ Occup Health 2010, 65:127-134. 10.1080/19338241003730887, 2936455, 20705572.
75. Hart R, Hickey M, Franks S. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 2004, 18:671-683. 10.1016/j.bpobgyn.2004.05.001, 15380140.
76. Ozucelik DN, Karcioglu O, Topacoglu H, Fowler JR. Toxicity following unintentional DDT ingestion. J Toxicol Clin Toxicol 2004, 42:299-303. 10.1081/CLT-120037432, 15362598.
77. Carson R. Silent Spring 1963, Houghton Mifflin: Greenburg.
78. Rogan WJ, Chen A. Health risks and benefits of bis(4-chlorophenyl)-1,1,1-trichloroethane (DDT). Lancet 2005, 366:763-773. 10.1016/S0140-6736(05)67182-6, 16125595.